Rhythm Pharmaceuticals, Inc. (RYTM)
90.19
-0.45
(-0.50%)
USD |
NASDAQ |
May 21, 16:00
90.17
-0.02
(-0.02%)
After-Hours: 19:59
Rhythm Pharmaceuticals Research and Development Expense (TTM) : 171.76M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Aldeyra Therapeutics, Inc. | 20.65M |
| Sarepta Therapeutics, Inc. | 896.74M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |
| Biogen, Inc. | 1.607B |
| MannKind Corp. | 72.56M |